Mice Sirt2 knockout mice (1) 
are deleted and Kras G12D is expressed in the pancreas simultaneously. Mice were housed, fed, and treated in accordance with the guidelines approved by the Northwestern University IACUC.
Immunohistochemistry
For immunohistochemistry (IHC), sections were stained using the protocol described below. Briefly, slides were heated via pressure cooker in DAKO retrieval buffer, and endogenous peroxidases quenched in 3% hydrogen peroxide in methanol for 30 min. Tissues were blocked with 5% BSA in PBS for 30 min and exposed to primary antibodies against BrdU 
Plasmids/transfection/infection
All plasmids for overexpressing SIRT2 have been described previously (1) . Flag-tagged KRAS and KRAS G12V constructs in pCMV2 vector were kindly provided by Lewis C. Cantley (Weil Cornell Medical College). HA-tagged KRAS and KRAS G12V constructs in pGCN vector were provided by Mark R. Philips (New York University). Site-directed mutagenesis to make K147 acetylation mutants (K147R and K147Q) as well as subcloning to a pCDH-GFP-puro vector (SBI, Systems Biosciences) were performed by Bioinnovatise. For transient overexpression,
293T cells were transfected using polyethylenimine (PEI) at a ratio of 3 μL PEI/μg DNA. For stable overexpression, 293T cells were used to produce viral particles to infect cells (5) . All cells were selected after treating with puromycin (Cellgro) at 2 µg/mL or G418 (Cellgro) at 200 µg/mL for 2 weeks. For knocking down mouse Kras, human SIRT2 and mouse Sirt2, target sequences (Kras: 5'-GGATTTGGTGCATGCAGTTGA-3', human SIRT2: 5'-AAGTAGTGACAGATGGTTGGC-3' and mouse Sirt2: 5'-TTCCAGCGTGTCTATGTTCTG-3') subcloned into a pLKO.1-puro vector (Dharmacon), were used to produce viral particles, followed by cell infection, and selection as described earlier.
For siRNA experiments, control siRNA (sc-37007) and mouse siSIRT2 (sc-40989) were bought from Santa Cruz Biotechnology.
Cell treatments
To stimulate KRAS signaling, cells were first starved for 24 h in 0.1% FBS medium followed by treatment with EGF (100 ng/mL) (Sigma). To inhibit the activity of endogenous sirtuins, cells were treated with 2 µM nicotinamide (NAM) (Sigma) for 12 h before lysing the cells. To specifically inhibit SIRT2, cells were treated with 5 µM AGK2 (Santa Cruz) for 12 h before cell lysis.
Intranasal infection
AdenoCRE (2.5x10 7 particles, Gene Transfer Vector Core, University of Iowa) was first mixed with Minimum Essential Medium (MEM) and 2 M CaCl 2 (final concentration 10 mM) in a final volume of 125 µL/mouse infected. Using a protein gel loading tip, half of the virus mixture (62.5 µL) was administered by placing the pipette tip at the opening of one nostril. The virus solution was slowly expelled from the tip while the mouse inhaled the drop that was forming. Mice were left to recover for 10-15 minutes. After breathing returned to normal, the procedure was repeated with the remaining 62.5 µL of the virus mixture. Mice were monitored for up to 6 months. All procedures were performed in accordance with approved Northwestern University IACUC protocol.
Western blotting
Cells or tissue samples were lysed using buffer A (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, and 5% glycerol), followed by sonication and centrifugation at 14,000 
Cellular transformation
Transformation ability of NIH3T3 cells was assessed by checking colonies formed by confluent cells. A total of 5 x 10 5 cells/well were seeded in 6-well tissue culture plates in complete medium which was replaced every 3-4 days. Fourteen days post-confluence, the cells were fixed and stained with crystal violet (Sigma), and the number of colonies composed of >50 cells was determined. All assays were performed three times. The mean ± SD was calculated from three independent experiments. Cellular transformation was also assessed by observing anchorageindependent growth using the soft agar assay. Briefly, 10 4 cells/well were seeded into 0.35% low melting point agarose (Lonza) on top of a 0.5% agarose layer in 6-well plates. After 3 weeks, colonies were fixed in methanol and stained with 0.1% crystal violet. For quantification, crystal violet-positive colonies were counted. All assays were performed three times. The mean ± SD was calculated from three independent experiments.
Deacetylation assays
Both in vitro and in vivo deacetylation assays were performed as described previously (5).
Dot blot assay
Samples (2 µL containing 10 ng -0.5 µg protein) were spotted onto a nitrocellulose membrane at the center of the grid using a narrow-mouth pipette tip. Membrane was left to dry followed by blocking of non-specific sites after incubation with 5% milk in Tris-Buffered Saline/Tween 20 (TBST) for 0.5-1 h at room temperature. Next, the membrane was incubated with the primary antibody diluted in 1% milk in TBST for 30 min at room temperature. After washing three times with TBST (3 x 5 min), the membrane was incubated for 30 min at room temperature with a secondary antibody conjugated to HRP. Finally, membranes were exposed to x-ray films following incubation with a chemiluminiscence reagent.
Custom anti-Ac-K147 antibody development
The anti-Ac-K147 antibody was generated by Eurogentec following the Speedy 28-day protocol.
For immunization of rabbits, a peptide carrying acetylated K147 (N-IETSAK(Ac)TRQGVD-C)
as well as a control non-acetylated peptide were synthesized and attached to keyhole limpet hemocyaninand (KLH) carrier. After purification, the raised antibody, together with the synthesized peptides used for immunization, was shipped to our laboratory where they were used in additional validation experiments.
GDP/GTP exchange
Cells were lysed following the same procedure as described for the Ras activity assay. 2 mg of cell lysate for each condition was used. For 2 mL total lysate, 40 µL 0.5 M EDTA pH 8.0 was added (for a final concentration of 10mM) followed by vortexing. Then 40 µL 100 mM GDP was added (for a final concentration of 2 mM). Sample was vortexed again and the mixture was incubated at 30°C for 15 minutes with constant agitation. Each 2 mL sample was split in 4
followed by addition of different amounts of GTPγS (10 mM) to the mixture to reach a final concentration of 0, 0.1, 0.5 and 1 mM. After incubating at 30°C for 15 minutes, the exchange reaction was terminated by placing the samples on ice, adding 32 µL of 1M MgCl2 (for a final concentration of 60mM) and vortexing. GTP-bound "active" KRAS was determined by using the , followed by elution with excess free Flag peptide according to the procedure described in (6) . Eluted samples were run on a 4-20% polyacrylamide gel, followed by silver staining (ThermoFisher Scientific).
Protein bands were cut and sent to the MSRC Proteomics Laboratory at Vanderbilt University for mass spectrometry analysis as described before (6) . Plasmid insert sequences were confirmed to be accurate by DNA sequencing, and each plasmid was transformed into E. coli BL21(DE3)/MAGIC cells. Cultures were grown in Terrific Broth supplemented with 100 µg/mL ampicillin and 30 µg/mL kanamycin at 37 °C until OD 600 = 0.8 and then induced with 1 mM isopropyl-b-D-thiogalactoside at 25 °C for ≈18 h. Bacteria were harvested by centrifugation, re-suspended in buffer A1 (50 mM Tris pH 8.3, 500 mM NaCl, 10 mM MgCl 2 , 0.1% Triton X-100, 5 mM β-mercaptoethanol), and lysed by sonication. After centrifugation at 30,000xg for 30 min, the soluble lysates were loaded onto a 5-mL Ni-NTA HisTrap column using the ÄKTA protein purification system (GE Healthcare). The column was washed with buffer B1 (10 mM Tris pH 7.5, 500 mM NaCl, 10 mM MgCl 2 , 50 mM imidazole)
followed by elution in the same buffer with 500 mM imidazole (buffer C1). , HATs, and wild-type Flag-SIRT2. Acetylated levels of both KRAS and KRAS G12V were determined after immunoprecipitation using an anti-Ac-K antibody followed by western blotting using an anti-HA antibody. Interaction of both KRAS and KRAS G12V with SIRT2 was confirmed after immunoprecipitation using an anti-HA antibody followed by western blotting using an anti-Flag antibody, whereas successful immunoprecipitation of both KRAS and KRAS G12V was confirmed by western blotting using an anti-HA antibody. Levels of expressed SIRT2 are shown after immunoblotting using an anti-Flag antibody. (J) 293T cells were transfected with either Flag-KRAS (upper) or Flag-KRAS G12V (lower) and cells were subsequently treated with nicotinamide and AGK2. The relative amounts of GTP-bound active Ras were determined through a specific protein interaction with Raf1-RBD. Levels of expressed KRAS and KRAS G12V are shown after immunoblotting using an anti-Flag antibody. (K) 293T cells were co-transfected with Flag-KRAS, HATs, and either HA-SIRT2 wt (wild-type SIRT2) or HA-SIRT2 dn (deacetylation null mutant SIRT2). KRAS activity was determined as described in (J). Levels of expressed KRAS and SIRT2 are shown after immunoblotting using anti-Flag and anti-HA antibodies, respectively. Tubulin is used as loading control. G12V in the absence (sample 1) or presence (sample 2) of exogenously expressed SIRT2. After immunoprecipitation using an anti-Flag antibody, samples were separated on a gel, and bands corresponding to Flag-tagged KRAS G12V were excised, in-gel trypsin digested, and analyzed by mass spectrometry. Identified peptides are highlighted in yellow, and acetylated lysines are indicated by red circles. K104 and K147 were found to be acetylated in sample 1, whereas K147 acetylation was not detected in sample 2. (B, C) Spectra for both sites found to be acetylated in sample 1 are shown. , KRAS G12V-K147R and KRAS G12V-K147Q after knocking down endogenous Kras was checked by measuring the number of cells for 6 consecutive days (A) and by determining the number of colonies formed after 21 days (B, C). For cell proliferation, data represent mean ± SD of three independent experiments, **p<0. 
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